Revolution Medicines, Inc.(RVMD US)
$186.99-0.700.37%Ext:$182.59-4.402.36%(Market Closed · 23:56:03 UTC)
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -436.4 | -600.1 | -1,131.3 | -1,371.7 | ||||||||
| Depreciation & Amortization | 9.3 | 11.8 | -27.0 | 46.0 | ||||||||
| Stock Based Compensation | 61.8 | 79.2 | 118.4 | 180.6 | ||||||||
| Change in Working Capital | 40.7 | 1.2 | 86.8 | 67.4 | ||||||||
| Other Non-Cash Items | -22.0 | -48.8 | 55.3 | 20.2 | ||||||||
| Net Cash from Operating Activities | -350.6 | -557.4 | -897.7 | -1,057.5 | ||||||||
| -Investments in Property, Plant & Equipment | -7.7 | -10.3 | -16.0 | -14.3 | ||||||||
| -Acquisitions Net | - | - | - | - | ||||||||
| -Purchases of Investments | -1,058.9 | -2,136.6 | -1,794.9 | -1,494.5 | ||||||||
| Sales/Maturities of Investments | 724.0 | 1,592.5 | 1,928.9 | 1,815.4 | ||||||||
| Other Investing Activities | - | - | - | - | ||||||||
| Net Cash from Investing Activities | -342.6 | -554.4 | 118.1 | 306.6 | ||||||||
| Net Debt Issuance | - | - | 244.2 | 244.2 | ||||||||
| Net Stock Issuance | 392.4 | 959.1 | 377.1 | 615.2 | ||||||||
| -Net Dividends Paid | - | - | - | - | ||||||||
| Other Financing Activities | 836.8 | 0.3 | 0.2 | -0.0 | ||||||||
| Net Cash from Financing Activities | 1,229.2 | 959.4 | 621.5 | 859.4 | ||||||||
| Effect of Forex Changes | -1.3 | -0.7 | - | - | ||||||||
| Net Change in Cash | 534.7 | -153.1 | -158.2 | 108.5 | ||||||||
| Cash at End of Period | 696.1 | 543.1 | 388.6 | 1,458.2 | ||||||||
| Operating Cash Flow | -350.6 | -557.4 | -897.7 | -1,057.5 | ||||||||
| -Capital Expenditure | -7.7 | -10.3 | -16.0 | -14.3 | ||||||||
| Free Cash Flow | -358.3 | -567.7 | -913.7 | -1,071.7 | ||||||||
